Biotechnology Get all the latest news from the field of biotechnology and its many applications, including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance, and market analysis.

Latest

Apr 19, 2019, 18:12 ET FDA permits marketing of first medical device for treatment of ADHD

The U.S. Food and Drug Administration today permitted marketing of the first medical device to treat attention deficit hyperactivity disorder (ADHD). ...


Apr 19, 2019, 17:15 ET Neurotrope Announces Inducement Grant to Newly-Appointed Chief Operating Officer and General Counsel

Neurotrope, Inc. (Nasdaq: NTRP), a clinical-stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases, including...


Apr 19, 2019, 14:21 ET Novel Technology to Produce Everyday Enzymes

From jeans to orange juice to laundry detergent: None would be possible without the activity of enzymes. Currently, enzymes used in industry are...


Apr 19, 2019, 11:15 ET FDA approves first generic naloxone nasal spray to treat opioid overdose

The U.S. Food and Drug Administration today granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, ...


Apr 19, 2019, 00:00 ET ACT Genomics Establishes NGS Laboratory to Offer Comprehensive Cancer Genomic Profiling Service in Japan

ACTmed, a joint venture between Canon Medical Systems Corporation (Headquarters: Otawara, Tochigi Prefecture, Japan; President and CEO: Toshio...


Apr 18, 2019, 16:30 ET The global biodefense market size is expected to reach USD 6.50 billion by 2025, growing at a CAGR of 4.5% over the forecast period

Biodefense Market Size, Share & Trends Analysis Report By Product (Anthrax, Small Pox, Botulism, Radiation/Nuclear), By Region (North America, Latin...


Apr 18, 2019, 16:00 ET Alkermes to Host Conference Call to Discuss First Quarter 2019 Financial Results

Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:30 a.m. ET (1:30 p.m. BST) on Thursday, Apr. 25, 2019, to...


Apr 18, 2019, 11:12 ET Parent Project Muscular Dystrophy Awards $100,000 Grant to Nationwide Children's Hospital to Further Explore GALGT2 Gene Therapy in Duchenne Muscular Dystrophy

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), announced that...


Apr 18, 2019, 10:37 ET Luminex Corporation First Quarter Earnings Release Scheduled for May 6, 2019

Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the first quarter ended March 31, 2019 on Monday, May 6, 2019. ...


Apr 18, 2019, 10:18 ET TAU BIO-LOGIC anuncia la humanización del TBL-100 que actúa ante la proteína tauC3 para el tratamiento de la EA y la PSP

AU BIO-LOGIC CORP ha anunciado hoy que, en colaboración con el grupo LifeArc, con sede en Reino Unido, ha humanizado con éxito un anticuerpo...


Apr 18, 2019, 09:30 ET TAU BIO-LOGIC Announces Humanization of Picomolar Affinity Monoclonal Antibody Targeting TauC3 Protein for the Treatment of Alzheimer's Disease and Progressive Supranuclear Palsy

TAU BIO-LOGIC CORP. announced today that in collaboration with the UK-based group LifeArc, it has successfully humanized a monoclonal antibody...


Apr 18, 2019, 09:30 ET TAU BIO-LOGIC kündigt die Humanisierung des monoklonalen Antikörpers Picomolar Affinity gegen das TauC3-Protein zur Behandlung von Alzheimer und progressiver supranuklearer Lähmung an

TAU BIO-LOGIC CORP. gab heute bekannt, dass sie in Zusammenarbeit mit der britischen Gruppe LifeArc erfolgreich einen monoklonalen Antikörper...


Apr 18, 2019, 09:30 ET TAU BIO-LOGIC annonce l'humanisation d'un anticorps monoclonal d'une affinité atteignant l'ordre du picomolaire, qui cible la protéine tauC3, pour le traitement de la maladie d'Alzheimer et de la paralysie supranucléaire progressive

TAU BIO-LOGIC CORP. a annoncé aujourd'hui qu'en collaboration avec le groupe basé au Royaume-Uni LifeArc, la société avait humanisé avec succès un...


Apr 18, 2019, 09:28 ET Medicinal Genomics announces Cannabis Pan-Genome project, a major advance in genetics for cannabis breeding

Medicinal Genomics Corp. (MGC), a pioneer in using genomics to improve the quality, quantity and safety of cannabis, announced the initiation of a...


Apr 18, 2019, 09:00 ET Grifols US donor centers exceed 250,000 pounds of food collected

Grifols, one of the world's three top providers of plasma-derived medicines to treat life-threatening diseases, today announced that its U.S. network ...


Apr 18, 2019, 09:00 ET Inovio Publishes Cancer Killing Data of Its Transformative DNA-encoded Bi-specific T Cell Engagers (dBiTEs™) in a Peer-reviewed Journal

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today the company's novel DNA-encoded Bi-specific T Cell Engagers (dBiTEs) generated potent...


Apr 18, 2019, 09:00 ET Actinium Pharmaceuticals, Inc. Announces Pricing of $16.5 Million Public Offering of Common Stock and Warrants

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium") today announced the pricing of an underwritten public offering of 42,860,000 shares ...


Apr 18, 2019, 08:39 ET Sharon Mates, David Daniel, and Gary Sachs Recipients of 2019 ISCDD Leadership Awards

The International Society for CNS Drug Development (ISCDD), a non-profit, independent society focused on improving CNS drug development, announced...


Apr 18, 2019, 08:30 ET Biotech Brief: FDA Fast Tracking Innovative Breakthrough Therapies For Cancer Patients

A recent headline from a report released by Friends of Cancer Research, made the following eye-opening statement: "ONE OF THE BIGGEST TREATMENT...


Apr 18, 2019, 08:07 ET Alafair Biosciences Raises Over $7.2 Million in Series B/B-1 Financing

Alafair Biosciences, Inc., a commercial-stage medical device company, announced that it raised over $7.2 million in an oversubscribed Series B/B-1...


Apr 18, 2019, 08:00 ET Hoth Therapeutics, Inc. to Ring NASDAQ Closing Bell on April 22, 2019

Hoth Therapeutics, Inc.(NASDAQ: HOTH), a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications...


Apr 18, 2019, 08:00 ET TB Alliance and Mylan Announce Global Collaboration to Commercialize Investigational Drug Pretomanid as Part of Two Regimens to Treat Tuberculosis (TB)

Non-profit drug developer, TB Alliance, and pharmaceutical company, Mylan N.V. (NASDAQ: MYL), today announced a global collaboration to make the...


Apr 18, 2019, 08:00 ET Hemopure Plays A Pivotal Role In A Pioneering Study Published in Nature

Hemoglobin Oxygen Therapeutics LLC (HbO2 Therapeutics), a world leader in oxygen-carrying solutions, today announces pioneering research conducted at ...


Apr 18, 2019, 08:00 ET PTC Therapeutics to Host Conference Call to Discuss First Quarter 2019 Financial Results

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its first quarter 2019 financial ...


Apr 18, 2019, 07:30 ET Moleculin Receives FDA Approval of Fast Track Designation for Annamycin

Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug...